Major Players - Thebaine Industry

Aug, 2023 - by CMI

Major Players - Thebaine Industry

The global thebaine market is anticipated to increase significantly as a result of the introduction of new initiatives to support drug misuse treatment. For instance, in 2018, the White House Administration under Trump sponsored a multi-million dollar effort to educate young individuals about opioid addiction. This campaign tries to prevent young people from acquiring opioids. This program also raises awareness by telling real-life drug addict stories to young people and teenagers. An investigation by the Substance Abuse and Mental Health Services Administration in 2018 found that the opioid problem kills 116 Americans on average per year. Individuals should be encouraged to overcome drug abuse addiction through the various treatments that are accessible by such government-organized campaigns and the high number of individuals dying from the opioid crisis in order to live a healthy life. Thebaine market expansion is also anticipated to be aided by an increase in patients who abuse drugs. Thebaine market growth is anticipated to be fueled by a strong pipeline of therapeutic options.

According to Coherent Market Insights, With a CAGR of -0.3% from 2023 to 2030, the global market for the drug Thebaine is anticipated to reach a value of USD 60 million in 2023 and USD 59 million by 2030.

Top Companies in the Thebaine Industry:

1. API Labs Inc.,

The company was founded in 2005 and is based in Toronto, Ontario, Canada. A business called API Labs is attempting to develop a vertically integrated poppy industry.Establishing a top-notch research center has been the first step in creating poppies that satisfy the demands of the commercial market.

2. Alcaliber S.A.

The company was started in 1973 and is based in Madrid, Madrid, Spain. Pharmaceuticals are offered by Alcaliber SA. The company raises opium poppy plants, produces its concentrate, and also extracts alkaloids from them. Alcaliber's goal is to create the highest-quality narcotic raw materials and generate derived active pharmaceutical components.

3. Sanofi S.A.

The business was founded in 1973 and is based in Paris, France. In addition to doing research, creating pharmacological products, producing them, and distributing them, mostly to the prescription market, Sanofi also creates over-the-counter medications. On November 18, 2021, it was announced that Sanofi would give $180 million to the French company Owkin.

4. Faran Shimi pharmaceutical Co.,

The company was started in 2001 and is located in Tehran, Iran. The business produces final dosage forms and high-quality active pharmaceutical ingredients.Salicylic acid was the first pharmaceutical intermediate that the company produced after being founded with the goal of generating pharmaceutical intermediate chemicals.

5. Mallinckrodt Pharmaceuticals

The company was started in 1867 and is based in Staines-upon-Thames, United Kingdom. The business produces imaging agents, generic medications, and specialized pharmaceuticals such adrenocorticotropic hormone. Mallinckrodt announced in June 2023 that real-world data on the use of extracorporeal photopheresis (ECP) in patients undergoing heart transplants would be published.

6. Noramco Inc,

The company was started in 1979 and is based in Athens, Georgia, United States. Noramco is a top manufacturer of speciality active pharmaceutical ingredients (APIs) that supports the development of both opioid and non-opioid medications for a variety of therapeutic uses. The Noramco Inc. Pharmaceutical components made by Noramco, Inc. are used to make drugs and medical equipment.

7. Tasmania Alkaloids Pvt. Ltd.

The firm was started in 1975 and is located in Tasmania, Australia. The business produces controlled substances. The company creates raw materials and active pharmaceutical components extracted from opium poppies for human medicinal formulations. The business is a global leader in the study, production, and export of botanical extracts and other refined goods.

*Definition: Opioid thebaine, commonly known as codeine methyl enol ether, is an alkaloid of the opioid class. Thebaine, a small component of opium, is chemically related to morphine and codeine, but instead of having depressing effects, thebaine has stimulant properties.

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.